Mode of delivery can alter an infant’s gut microbiota, irrespective of maternal antibiotic exposure, and this in turn could impact respiratory health in the first year of life, according to research presented at ECCMID.
In this infographic we take a look at the RSV vaccines currently in the clinical pipeline and their target population from Phase I to Phase III.
Take a look behind the scenes of a recent Future Microbiology paper as we ask the authors about the challenges in treating respiratory tract infections and how nanomedicines could help.
New data analysis of three clinical trials has suggested that a precision medicine approach could allow some pulmonary TB patients to have significantly shorter treatment periods.
Roche has announced the FDA approval of Xofluza™, the first and only single-dose oral medicine approved to treat flu.
On the day of UNGA’s first-ever high-level meeting on tuberculosis we summarize the key points from the WHO 2018 Global Tuberculosis Report and what this meeting could mean for accelerating progress.
New research indicates that false negative RIAT results could delay antiviral therapy for half of patients admitted to intensive care units.
In this interview, we speak to Dr. Bryan Kraft, an Assistant Professor of Medicine at Duke University, about his research into carbon monoxide as a potential therapy to treat ARDS and the clinical trial for this therapy that is currently underway.
In this interview, take a look behind the scenes of a recent Future Microbiology review on influenza virus infection in pregnancy with author, Lucy Somerville.
Researchers have developed a novel test that can measure the levels of RNA or proteins in human cells to accurately identify viral respiratory infections
